Press release
Ventilator-associated Pneumonia (VAP) Market is Trending with Major Key Leaders - Merck & Co., Inc., Adenium Biotech ApS , AstraZeneca, MedImmune , Nabriva Therapeutics AG
Global Ventilator-associated Pneumonia (VAP) Market - Overview
Patients in critical care require aid for respiration. Many of them suffer from disease like heart disease which require continuous monitoring by healthcare staff in intensive care unit. Ventilator- associated pneumonia is prevalent among patients admitted to ICUs. It is a significant cause of morbidity and mortality in ICU.
Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/1377
This disease results from contaminated pathogen secretions in the lungs. Prolonged use of ventilators in ICU favor the growth of this market. Increase in hospital acquired infection is also another factor contributing for the growth of this market. Prevention of ventilator-associated pneumonia is important to protect the health of patients suffering from life threating diseases.
Global Ventilator-associated Pneumonia (VAP) Market - Competitive Analysis
Philips Healthcare is one of the major market player in ventilation devices with its products named Respironic NM3, Respironic V680 and Respironic Trilogy 202.Medtronic plc. Is another major market player in this market with product like Puritan Bennet 980, Newport HT70 and Newport e360.ResMed manufactures ventilation devices named Astral 150 and Astral 100?
Global Ventilator-associated pneumonia (VAP) Market - Regional Analysis
Globally, Ventilator-associated pneumonia (VAP) market consists of four regions Americas, Europe, Asia Pacific and Middle East & Africa. America is the largest market for Ventilator-associated pneumonia (VAP) whose growth is contributed to increase in prevalence of smoking leading to lung diseases, large number of patients suffering from chronic heart diseases and demand of mechanical ventilators.
Access Report Details with TOC @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377
The market is growing continuously in Europe due to extensive demand of medical devices in hospitals, and increasing healthcare expenditure. Asia Pacific is expected to be the fastest growing market owing to increase in environmental pollution, high incidence of asthma & chronic obstructive pulmonary disease and large patient pool.
Moreover, Awareness regarding prevention of hospital acquired infection, pneumonia and quality control measures taken by hospitals for control of nosocomial infection favor the growth of this market. Increasing ageing population and incidence of infectious disease too contribute for the growth of this market in Asia Pacific. On the other hand, the Middle East & Africa region are likely to have a limited but steady growth in the market.
Global Ventilator-associated pneumonia (VAP) -Major Points from TOC
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Ventilator-associated pneumonia (VAP) Market, By Type
Chapter 7. Global Ventilator-associated pneumonia (VAP) Market, By Treatment
Chapter 8 Global Ventilator-associated pneumonia (VAP) Market, By End User
Chapter 9. Global Ventilator-associated pneumonia (VAP) Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Avail Excusive Discount @ https://www.marketresearchfuture.com/check-discount/1377
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ventilator-associated Pneumonia (VAP) Market is Trending with Major Key Leaders - Merck & Co., Inc., Adenium Biotech ApS , AstraZeneca, MedImmune , Nabriva Therapeutics AG here
News-ID: 1225023 • Views: …
More Releases from Market Research Future
Jerky Market to Reach USD 7.7 Billion by 2032 at 6.04% CAGR Driven by On-the-Go …
The global jerky market is experiencing a surge in popularity as consumers increasingly turn to convenient, protein-rich, and shelf-stable snack options. According to recent industry data, the jerky market was valued at USD 4.45 billion in 2023 and is projected to reach USD 7.69 billion by 2032, growing at a CAGR of 6.04% between 2024 and 2032.
This growth is largely fueled by changing consumer lifestyles, rising demand for portable snacks,…
Ultrasound Devices Market Set to Grow to USD 15.2 Billion at 5.98% CAGR by 2035
Market Overview
The Ultrasound Devices Market is estimated to be valued at USD 7.57 billion in 2024 and is projected to reach USD 15.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 5.98% from 2024 to 2035. Increasing demand for non-invasive diagnostic procedures, rising prevalence of chronic diseases, and advancements in imaging technology are the major factors driving market growth. Ultrasound devices are widely used for diagnostic…
The Radiology Services Market Expected to Cross USD 65 Billion at a 4.51% CAGR b …
Market Overview
The Radiology Services Market is estimated to be valued at USD 40.02 billion in 2024 and is projected to reach USD 65 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.51% during the forecast period. The rising prevalence of chronic diseases, growing demand for early disease diagnosis, and advancements in medical imaging technologies are key factors fueling the market growth. Radiology services encompass diagnostic imaging…
Precision Medicine Market Projected to Achieve USD 227.13 Billion at a 16.10% CA …
Precision Medicine Market Overview
The Precision Medicine Market is projected to be valued at USD 91.4 billion in 2024 and is expected to reach USD 227.13 billion by 2035, expanding at a robust compound annual growth rate (CAGR) of 16.10% during the forecast period. Rising adoption of genomics, advances in big data analytics, and the growing demand for personalized healthcare solutions are driving the market's momentum. Precision medicine enables treatment…
More Releases for VAP
Ventilator Associated Pneumonia (VAP) Market Demonstrates Robust Growth Potentia …
New Jersey, US State: "The global Ventilator Associated Pneumonia (VAP) market in the Healthcare and Pharmaceuticals category is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 6.5% from 2025 to 2031. With rising industrial adoption and continuous innovation in Healthcare and Pharmaceuticals applications, the market is estimated to hit USD 2.5 billion in 2024, highlighting strong growth potential throughout the forecast period."
Ventilator Associated Pneumonia (VAP)…
Ventilator-associated Pneumonia (VAP) Market likely to experience a steep rise i …
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Ventilator-associated Pneumonia (VAP) Market: Increase in Hospital Acquired in I …
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Ventilator Associated Pneumonia (VAP) Market size, Share, Growth & Forecast 2026
Ventilator Associated Pneumonia (VAP) Market Overview: 2026
This report focuses on the global Ventilator Associated Pneumonia (VAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ventilator Associated Pneumonia (VAP) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Inquire For Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10Z1992/Global_Ventilator_Associated_Pneumonia_VAP_Market
The key players covered in this study
Philips Respironics
Hoffrichter
…
Ventilator Associated Pneumonia (VAP) Therapeutics Market: Industry Size, Share, …
Ventilator Associated Pneumonia (VAP) Therapeutics Market 2020-2025 Industry research report covers the market landscape and its growth prospects over the coming years, the report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.
Get Sample Copy of this Report…
Global Business Forecast And Trends In Ventilator Associated Pneumonia (VAP) Mar …
Albany, New York, March 17, 2017: A latest research report labeled as “Ventilator Acquired Pneumonia (VAP) Pipeline Review, H1 2017” has been added to the vast portfolio of Market Research Hub’s online research offerings. The Report provides a professional and in-depth overview of the Ventilator Acquired Pneumonia Disease market. The report delivers a thorough analysis of the market current status and future growth prospects for the forecast period of 2017-2022.…
